2 results
Approved WMOPending
To assess the effect of betahistine on the severity / intensity of motion sickness
Approved WMOCompleted
This study is designed to evaluate the immunogenicity and tolerability of V503 in young men, 16 to 26 years of age, in comparison to GARDASIL® in young men, 16 to 26 years of age. The safety and immunogenicity data will be used to bridge GARDASIL®…